;
New #HBV guidelines from @AASLDtweets & @IDSAInfo! Taking steps for expanding treatment!
🏅 The @TherVacB_EU consortium proudly congratulates our Coordinator Prof. @UlrikeProtzer - awarded the German Medical Award 2025 as Female Doctor of the Year! 🎊
Her pioneering #HepatitisB research and leadership in advancing #TherVacB bring us closer to a functional #cure.🌐
🎉 Congratulations to Prof. @UlrikeProtzer on receiving the Germany Federal Cross of Merit for her groundbreaking work in #Virology and advancing curative therapies for #HepatitisB.
Proud to see the vision behind #TherVacB recognised at this level! 👏
#HepBCure #EUHealth
About 254 mil. people across the globe live with chronic hepatitis B infection.
Could @TherVacB_EU's new clinical trial for a newly designed vaccine, deliver an affordable & curative immunotherapeutic approach to the disease?
Discover their research: https://link.europa.eu/QMFx3J